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ABSTRACT                                                                                                                                                                                                       
Background: HIV pandemic has continued to be a huge challenge in Nigeria, with the problem of stigmatization reducing the 
chances of early determination of the HIV status of pregnant women, which may increase the chances of transmission to the 
child from the mother. Hypotheses tested were the influence of maternal antiretroviral therapy (ART) use and infant’s feeding 
option on baby’s final early infant diagnosis (EID) outcome. The study was aimed at determining the trend as well as diagnosis 
of HIV infection in exposed infants. It will also determine among infants the factors associated with the transmission of the 
infection from their mothers.  
Methods: This study was a prospective cohort study of HIV-exposed infants conducted in Ekiti State, South Western Nigeria, 
between June 2015 and June 2017. Dried Blood Spots (DBS) were analyzed using polymerase chain reaction technique. All data 
were statistically analyzed, using statistical package for the social sciences (SPSS) and statistical test of significance was 
performed with Chi-Square test.  
Results: A total of 200 infants were included in the study, 91 (45.5%) female and 109 (54.5%) male. Three (1.5%) babies were 
confirmed positive after cessation of all exposures. Maternal antiretroviral therapy (ART) use has significant effect on baby 
early infant diagnosis (EID) outcome (χ² = 65.40, df = 2, P = 0.001). Infant feeding option has significant effect on baby early 
infant diagnosis (EID) outcome (χ² = 132.67, df = 2, P = 0.001). Baby’s mode of delivery have higher association with the final 
EID outcome of the baby (OR: 1.018, 95% CI: 0.998 – 1.038).  
Conclusion: ART administration to both HIV-infected mothers and their babies has demonstrated an effective mechanism in 
the elimination of mother-to-child transmission (eMTCT), as this is evident in the very low positivity outcome. However, the 
degree to which Cuba, Armenia, Belarus, and Thailand have eliminated HIV transmission from mother-to-baby is achievable in 
Nigeria through provision of universal access to health care. 
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RÉSUMÉ              
Contexte: Au Nigéria, la pandémie de VIH continue de poser un problème énorme, le problème de la stigmatisation réduisant 
les chances de déterminer rapidement le statut VIH des femmes enceintes, ce qui peut augmenter les risques de transmission de 
la mère à l’enfant. 
Les hypothèses testées étaient l’influence de l’utilisation du traitement antirétroviral par la mère et de l’option d’alimentation 
du nourrisson sur le résultat final du diagnostic précoce du nourrisson. L'étude visait à déterminer la tendance ainsi que le 
diagnostic d'infection par le VIH chez les nourrissons exposés. Il déterminera également chez les nourrissons les facteurs 
associés à la transmission de l'infection par leur mere 
 
Méthodes: Cette étude était une étude de cohorte prospective menée entre juin 2015 et juin 2017 dans l'État d'Ekiti, dans le sud-
ouest du Nigéria, auprès de nourrissons exposés au VIH. Les taches de sang séché ont été analysées à l'aide de la technique de 
réaction en chaîne de la polymérase. Toutes les données ont été analysées statistiquement, en utilisant un logiciel 
statistiquepour les sciences sociales (SPSS) et un test statistique de signification a été réalisé avec un test de Chi-Square.  
 
Résultats: Un total de 200 nourrissons ont été inclus dans l'étude, 91 (45,5%) femmes et 109 (54,5%) hommes. Trois bébés (1,5%) 
ont été confirmés positifs après la cessation de toutes les expositions. L'utilisation du traitement antirétroviral par la mère a un 
effet significatif sur l'issue du diagnostic précoce chez le nourrisson (ID² = 65,40, df = 2, p = 0,001). L'option d'alimentation du 
nourrisson a un effet significatif sur l'issue du diagnostic précoce du nourrisson (ID² = 132,67, df = 2, p = 0,001). Le mode 
d’accouchement du bébé est davantage associé au résultat final de l’EID du bébé (OR: 1,018, IC 95%: 0,998 - 1,038). Conclusion: 
l'administration d'un traitement antirétroviral aux mères infectées par le VIH et à leurs bébés a démontré un mécanisme efficace 
pour éliminer la transmission mère-enfant (eMTCT), ce qui est évident dans le résultat de très faible positivité. Cependant, il est 
possible d’atteindre au Nigéria le degré auquel Cuba, l’Arménie, le Bélarus et la Thaïlande ont éliminé la transmission du VIH 
de la mère à l’enfant grâce à un accès universel aux soins de santé. 
 
Mots clés: nourrisson, mère, tache de sang séché, réaction en chaîne de la polymérase 
 
INTRODUCTION 
Prevention of mother-to-child transmission of HIV (PMTCT) 
is the most successful HIV prevention intervention globally 
(1). Elimination of mother-to-child transmission of HIV 
(eMTCT) is key to the global effort to combat sexually 
transmitted infections (STIs) and to end AIDS by the year 
2030. Cuba was the first country validated by the World 
Health Organization (WHO) in 2015 to have successfully 
eliminated mother-to-child transmission (MTCT) of HIV and 
syphilis. Countries such as Thailand, Armenia, Belarus and 
Republic of Moldova have gone on to join Cuba in 2016 (2). 
The countries ensured early access to pre-natal care, HIV & 
syphilis testing for pregnant women and their partners and 
treatment for women who test positive, as well as their 
babies. They provided reproductive health in formation, 
engaged communities and conducted outreach to 
marginalized populations, in a manner consistent with basic 
human rights and gender equality, showing a perfect 
integration of maternal and child health with sexual & 
reproduction health and HIV services (2). 
Mother-to-child transmission (MTCT) of HIV resulted in 
approximately 370,000 infant infections worldwide in 2009 
(3).  The same year, estimated 2.5million children worldwide 
were living with HIV, mostly a consequence of MTCT and 
more than 90% of these children are in Sub-Saharan Africa 
(3). Mother-to-child transmission of HIV can occur in uterine 
(in-utero), during delivery (intrapartum) or after birth 
(postnatally) through breastfeeding. Strategies to reduce 
MTCT focus on these periods of exposure and include the 
use of antiretrovirals (ARVs), caesarean section before the 
onset of labour or rupture of membranes and even may 
involve complete avoidance of breastfeeding (4). The 
combination of these interventions when effectively 
followed, reduce the risk of MTCT to as low as 1-2% (5). In 
the absence of intervention, 30-45% of all infants born to HIV 
positive mothers will be infected and 10-20% will be infected 
through breastfeeding (6). 
In infants born from HIV-infected women, maternal anti-
HIV antibodies cross the placenta and persist in infant blood 
for up to 18 months. These antibodies usually represent 
exposure to maternal HIV rather than the true infants less 
than 18 months by antibody-based tests. Only virological 
tests can be used for an accurate diagnosis of HIV before 
18months of age (7). A dried blood spot (DBS) is the 
sampling method used for HIV-exposed infants. Infants can 
be tested from six weeks of age and sample collection is 
from finger, toe or heel depending on the age and weight 
of the baby (8). 
A research work published in 2014 on the impact of HIV 
PMTCT reported 7.0% of the children to be positive, with 
highest prevalence found among children in age-group 6-18 
months (16.1%) (9). An overall prevalence of 16.98% of 
postnatal HIV was observed in a study on PMTCT published 
in 2010 (10). In Tanzania, an overall MTCT prevalence rate of 
6.3% was reported, with infants on exclusive breastfeeding 
at the time of first DBS PCR was 86.5% (11). Another 
research in eastern Cameroon, published in 2013, reported 
that 50% of the infants were exclusively breastfed and based 
on the first PCR tests data, an overall prevalence of 11.6% 
was reported (12). In 2010, a study carried out in Malawi 
showed that 13.8% of the children born to HIV-positive 
mothers in 2009 were themselves HIV- positive as infants 
(13). In China, 4.4% mean HIV-positive rate of exposed 
infants was reported (14). Meanwhile, only 1.5% & 1.3% of 
babies within 18-month PMTCT program were confirmed 
positive in year 2013 & 2014 respectively after all exposure 
cessation in Western Nigeria (15). This study is therefore 
designed to determine the diagnosis and trend of HIV 
infection in exposed infants and the factors associated with 
mother-to-child transmission (MTCT) among the infants. 
RESEARCH HYPOTHESIS 
• Maternal antiretroviral has no significant effect on 










This study was a prospective cohort study of all HIV-
exposed infants enrolled at health facilities in Ekiti State 
from June 2015 and June 2017. The study population was 
HIV-exposed infants whose second (i.e. final) early infant 
diagnosis (EID) result has been determined by HIV nucleic 
acid testing polymerase chain reaction (PCR) and baby’s 
final outcome (alive/dead) is known. Relevant data such as 
age, sex, ARV therapy for mother and baby, infants feeding 
choices, place of delivery, duration of HAART use, HIV 
DNA results, among others were analysed. Results of 
samples analysed were received as dried blood spots (DBS) 
collected from each infant and analysed at the PCR 
Laboratory at State Specialist Hospital Akure Ondo State 
with an automated real-time amplification and detection of 
DNA using a qualitative DNA polymerase chain reaction 
(PCR) analyser by (Roche Molecular Diagnostics, Basel, 
Switzerland). HIV testing was also done at the Federal 
Teaching Hospital Ido Ekiti, State Specialist Hospital Ikere 
Ekiti & Ekiti State University Teaching Hospital Ado Ekiti. 
The data analysis was done using statistical package for the 
social sciences (SPSS) for windows version 23.0 software 
(SPSS Inc; Chicago, IL, USA). Frequency counts were 
generated for all variables and statistical test of significance 
was performed with chi-square test. Significance was fixed 
at P < 0.05 and highly significant when P < 0.01. 
RESULTS 
A total of 200 infants were included in the study with mean 
age (in months) 13.80 ± 1.20, 91 (45.5%) female and 109 
(54.5%) male. The research outcomes showed that majority 
of the children were breastfed exclusively, with the main 
mode of delivery being spontaneous vaginal delivery (SVD), 
173 (86.5%) while one hundred and seven (53.5%) of the 
mothers had antiretroviral therapy started during 
pregnancy. Nearly 60% of the mothers used recommended 
first line regimen Tenofovir/Lamivudine/Efavirenz while 
most of the babies took single dose nevirapine. 
Three (1.5%) babies were confirmed positive after cessation 
of all exposures, largely breastmilk. Maternal antiretroviral 
therapy (ART) use was found to have a significant effect on 
baby early infant diagnosis (EID) outcome (χ² = 65.40, df = 2, 
P = 0.001) while infant feeding option also had significant 
effect on baby early infant diagnosis (EID) outcome (χ² = 
132.67, df = 2, P = 0.001). Baby’s mode of delivery was also 
found to have higher association with the final EID outcome 
of the baby (OR: 1.018, 95% CI: 0.998 – 1.038). 
The full results are captured in tables: 
 
TABLE 1: CHARACTERISTICS OF INFANTS AND MOTHERS 
 
CHARACTERISTICS Frequency % 













































MODE OF DELIVERY 
Spontaneous Vaginal Delivery (SVD) 












PLACE OF DELIVERY 
Mission 
Primary Healthcare Centre 
Private Clinic  
Secondary Healthcare Facility 























HAART started before pregnancy 
HAART started during pregnancy 
















































BABY FEEDING OPTION 
Exclusive Breastfeeding (EBF) 
Breastmilk Supplement (EBS) 



































































TABLE 2 – CHI SQUARE RESULT SHOWING EFFECT ON BABY EARLY INFANT DIAGNOSIS (EID) OUTCOME 
VARIABLES (HYPOTHESES) χ²  df       Critical value Decision        P-Value 
 
Maternal Antiretroviral  65.40  2       5.99  Rejected       0.001 
Therapy (ART) use does 
not have significant effect 
on baby early infant diagnosis 
(EID) outcome  
 
Infant feeding option does  132.68  2       5.99  Rejected       0.001  
not have significant effect 
on baby early infant diagnosis 
(EID) outcome   
 






TABLE 3 – ODDS RATIO (OR) TABLE 
Variables      OR          95% CI____________ 
Estimated odds that mode of baby delivery   1.018   0.998 – 1.038 
have effect on baby final EID outcome  
 
 
FIGURE SHOWING THE TYPE OF ARV USED BY MOTHER 
 
DISCUSSION 
The outcome of this study reveals a positivity rate of 
1.5% after second EID test. The positivity rate is 
similar to previous research outcome in Western 
Nigeria where 1.5% & 1.3% of babies within 18-month 
PMTCT program were confirmed positive in year 
2013 & 2014 respectively after all exposure cessation 
in Western Nigeria (15). It is however lower than 
those reported in various other studies such as 7.0% 
reported in 2014 & 16.98% reported in 2010 
respectively (9, 10), 6.3% positivity reported in 
Tanzania (11), 11.6% reported in Eastern Cameroon in 
2013 (12), 13.8% & 4.4% positivity rates reported in 
Malawi & China (13, 14).This prevalence outcome is a 
great improvement over most of the previous studies 
although very similar to the previous Western Nigeria 
study outcome. The low positivity rate might be 
attributed to enhanced spread of programmes now 
targeting the elimination of HIV infection to children 
through the mothers especially with utilization of 
updated guidelines where most positive mothers are 
on antiretroviral (ARV) therapy either before 
pregnancy or commenced during pregnancy, with 
98.0% of the mothers on ARV therapy and infants 
even born to mothers with HIV who are at high risk 
of acquiring HIV now receive dual prophylaxis for 
extended period showing strict adherence to the new 
national guidelines, with its main role in reducing 
HIV transmission. This outcome suggests therefore 
that the commencement of ARV prior or during 
pregnancy had a great impact on the babies’ status 
outcome. Moreover, another contributory factor is the 
fact that the babies receive treatment as soon as 
possible after birth, mostly a single-dose nevirapine, 
from birth for a period of six weeks, after which the 
drug is replaced with cotrimoxazole. Infections to 
these few babies could be due to poor viral 
suppression which could not be ascertained in this 
study, as the HIV viral load, used to determine how 
well antiretroviral therapy (ART) is controlling the 






as it was just beginning to be fully optimized during 
the course of this study. It is therefore recommended 
that mixed feeding especially within the first 6 
months, should be highly discouraged.  
The Chi Square analysis in table 2 shows that 
maternal antiretroviral therapy use (χ² = 65.40, df = 2, 
P = 0.001) & infant feeding option (χ² = 132.68, df = 2, 
P = 0.001) have significant effect on baby early infant 
diagnosis (EID) outcome, indicating that the 
antiretroviral therapy used before or during 
pregnancy and exclusive breastfeeding being the 
most common baby feeding option in this study 
cohort enhanced the baby eventual outcome after the 
second EID result. It is thus recommended that partial 
breastfeeding with complimentary food, should be in 
place after 6 months to enhance HIV-free child 
survival.  
CONCLUSION:                                                                              
ART administration to both HIV-infected mothers 
and their babies has demonstrated an effective 
mechanism in the elimination of mother-to-child 
transmission (eMTCT), as this is evident in the very 
low positivity outcome. However, the degree to 
which Cuba, Armenia, Belarus, and Thailand have 
eliminated HIV transmission from mother-to-baby is 
achievable in Nigeria through provision of universal 
access to health care.  
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